Nonrelapse mortality after CAR T-cell therapy in large B-cell lymphoma: a systematic review and meta-analysis
Year: 2026
Type: review
Study design: Systematic Review
Abstract: • Non-relapse mortality after CAR T-cell therapy is a time-sensitive parameter indicating the relevance for follow-up adjustment • Both prevalence and patterns of non-relapse mortality vary across the approved CAR T-cell products
Institutions: Paracelsus Medical University, Kite (United States)
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,000
OpenAlex ID: W7124833814